Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Integra LifeSciences Acquires Two Schaerer Mayfield Lines

By HospiMedica staff writers
Posted on 01 Jun 2004
The acquisition of two new product lines for about U.S.$20 million has been announced by Integra LifeSciences Holdings Corp. More...
(Plainsboro, NJ, USA). The lines are the Mayfield Cranial Stabilization and Positioning Systems and the Budde Halo Retractor System, both from Shaerer Mayfield, USA, Inc. (Cincinnati, OH, USA), formerly the Ohio Medical Instrument Company.

The Mayfield and Budde lines include skull clamps, headrests, reusable and disposable skull pins, blades, retractor systems, and spinal implants. The acquired operations include a facility located in Cincinnati that manufactures, packages, and distributes Mayfield and Budde stabilization products, as well as a broad line of related instruments and disposables used in many neurosurgical and spinal procedures. In addition, Integra entered into a long-term license with SM USA, Inc., a wholly owned subsidiary of Shaerer Mayfield USA, Inc., for the use of the Mayfield name in connection with the acquired business.

Integra NeuroSciences designs, manufactures, and sells implants, devices, and monitors used in neurosurgery, neurotrauma, and related critical care. "This acquisition strengthens Integra's position as the industry leader in neurosurgery and neurotrauma,” said Stuart M. Essig, president and CEO of Integra. "It allows us to continue to broaden and strengthen the product lines offered by our well-trained and experienced sales group.”

Schaerer Mayfield USA, Inc. is a subsidiary of Schaerer Mayfield Holding, AG, a company in Nidau, Switzerland, founded in 1892.




Related Links:
Integra LifeSciences
Schaerer Mayfield USA

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.